Malignancies after heart transplant

Pharmacology, Toxicology and Pharmaceutical Science

• Immunosuppressive Agent 100%
• Skin Cancer 50%
• Lung Cancer 50%
• Intestine Cancer 50%
• Bladder Carcinoma 50%
• Solid Malignant Neoplasm 50%
• Prostate Carcinoma 50%
• Adenocarcinoma 50%
• Disease 50%
• Vascular Disease 50%
• Posttransplant Lymphoproliferative Disease 50%
• Abdominal Cancer 50%

Medicine and Dentistry

• Heart Graft 100%
• Cancer 100%
• Transplantation 33%
• Diseases 16%
• Population 16%
• Adenocarcinoma 16%
• Prostate Carcinoma 16%
• Bladder Carcinoma 16%
• Solid Malignant Neoplasm 16%
• Immunosuppressive Treatment 16%
• Lung Cancer 16%
• Oral Cavity 16%
• Posttransplant Lymphoproliferative Disease 16%
• Intestine Cancer 16%
• Abdominal Cancer 16%
• Vascular Disease 16%
• Immunosuppressive Drug 16%
• Skin Cancer 16%